We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$3.3B
AUM Growth
+$481M
Cap. Flow
+$53.5M
Cap. Flow %
1.62%
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
186
Closed
428

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$41.4M
2
XLRN
Acceleron Pharma
XLRN
+$7.85M
3
BHC icon
Bausch Health
BHC
+$7.4M
4
ALB icon
Albemarle
ALB
+$6.62M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.61M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$10M
3
AMGN icon
Amgen
AMGN
+$7.37M
4
CBRL icon
Cracker Barrel
CBRL
+$5.6M
5
COST icon
Costco
COST
+$5.44M

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.53%
2 Healthcare 3.46%
3 Communication Services 1.55%
4 Technology 0.91%
5 Consumer Discretionary 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMF icon
576
CALL
OneMain Financial
OMF
$7.08B
$553K 0.02%
+10,000
New +$581K
VTR icon
577
Ventas
VTR
$45.4B
$552K 0.02%
+10,000
New +$573K
DCPH
578
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$547K 0.02%
+16,100
New +$514K
TUP
579
CALL
DELISTED
Tupperware Brands Corporation
TUP
$539K 0.02%
+25,500
New +$571K
RUBY
580
CALL
DELISTED
Rubius Therapeutics, Inc
RUBY
$536K 0.02%
+30,000
New +$653K
RUBY
581
PUT
DELISTED
Rubius Therapeutics, Inc
RUBY
$536K 0.02%
+30,000
New +$653K
NIO icon
582
NIO
NIO
$9.02B
$534K 0.02%
+15,000
New +$616K
PTGX icon
583
CALL
Protagonist Therapeutics
PTGX
$9.28B
$532K 0.02%
+30,000
New +$1.28M
PTGX icon
584
PUT
Protagonist Therapeutics
PTGX
$9.28B
$532K 0.02%
+30,000
New +$1.28M
PWP icon
585
CALL
Perella Weinberg Partners
PWP
$1.04B
$530K 0.02%
40,000
-30,000
-43% -$400K
STZ icon
586
Constellation Brands
STZ
$21.1B
$527K 0.02%
+2,500
New +$546K
SIRI icon
587
CALL
SiriusXM
SIRI
$9.95B
$525K 0.02%
8,610
-1,340
-13% -$84.2K
SAN icon
588
PUT
Banco Santander
SAN
$213B
$516K 0.02%
142,500
– –
PPD
589
PUT
DELISTED
PPD, Inc. Common Stock
PPD
$515K 0.02%
11,000
-48,000
-81% -$2.22M
HAIN icon
590
Hain Celestial
HAIN
$57.2M
$513K 0.02%
+12,000
New +$475K
CCXI
591
DELISTED
ChemoCentryx, Inc.
CCXI
$513K 0.02%
+30,000
New +$467K
DCPH
592
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$510K 0.02%
+15,000
New +$479K
RLAY icon
593
PUT
Relay Therapeutics
RLAY
$4.16B
$508K 0.02%
+16,100
New +$542K
CVET
594
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
$506K 0.02%
27,900
– –
CGC
595
CALL
Canopy Growth
CGC
$389M
$505K 0.02%
3,640
– –
MELI icon
596
Mercado Libre
MELI
$92.7B
$504K 0.02%
300
-200
-40% -$346K
AVDL
597
DELISTED
Avadel Pharmaceuticals
AVDL
$503K 0.02%
51,313
+16,313
+47% +$128K
IONS icon
598
PUT
Ionis Pharmaceuticals
IONS
$7.85B
$503K 0.02%
15,000
-61,700
-80% -$2.32M
FPAC
599
CALL
DELISTED
Far Peak Acquisition Corporation
FPAC
$498K 0.02%
+50,000
New +$498K
KRYS icon
600
PUT
Krystal Biotech
KRYS
$9.97B
$496K 0.02%
+9,500
New +$562K
22 23
24
25 26

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q3 2021 Portfolio in Review

As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

SG3 Management's Q3 2021 filing shows 403 new, 148 increased, 186 reduced and 428 closed positions. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M. The largest sale was Alphabet (Google) Class A, an estimated $24.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 92% a quarter earlier, followed by Healthcare and Communication Services.

  • SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
  • SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
  • SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
  • SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
  • SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
  • SG3 Management opened 403 new positions and closed 428 in Q3 2021.
  • SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.